Dean Kostakos
Podiatrist · Roswell, GANPI 1417056847
Payments from drug & device makers
Across 26 payments — averaging $72.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$1K
- Medtronic$81
- Organogenesis Inc.$75
- Novo Nordisk$71
- Amgen$48
- Amarin Pharma, Inc.$41
- plus $117 from 6 others
What the payments were for
- Travel & lodging$1,13461%
- Food & beverage$73839%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 6 | $1,438 |
| Medtronic | 1 | $81 |
| Organogenesis Inc. | 2 | $75 |
| Novo Nordisk | 4 | $71 |
| Amgen(2 entities) | 3 | $48 |
| Amarin Pharma, Inc. | 2 | $41 |
| Merck | 2 | $27 |
| AbbVie | 2 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Seqirus USA Inc | 1 | $18 |
| Osiris Therapeutics Inc. | 1 | $15 |
| Orthofix Medical, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty$826
- Lapiplasty System$395
How this compares
$1,872 in reported general payments places this provider in the 55th percentile of 177 podiatrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 44 | $412 |
| Ketoconazole | 25 | $390 |
| Gabapentin | 39 | $305 |
| Methylprednisolone | 57 | $280 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $251 |
| Clindamycin Hcl | 27 | $187 |
| Mupirocin | 21 | $177 |
| Doxycycline Hyclate | 13 | $158 |
| Terbinafine Hcl | 42 | $157 |
| Cephalexin | 21 | $126 |
| Allopurinol | 26 | $118 |
| Meloxicam | 39 | $105 |
| Diclofenac Sodium | 22 | $102 |
| Amoxicillin | 16 | $66 |
| Ciprofloxacin Hcl | 13 | $35 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Roswell
- Allen RaphaelSmyrna$336K
- Ira KrausFort Oglethorpe$247K
- Janaki NadarajahMartinez$208K
- Stephen BarrettMarietta$82K
- Mohammad SharifAtlanta$79K
- Craig CamastaAtlanta$49K
- Ryan FitzgeraldCanton$43K
- Margo JimenezAtlanta$19K
- Samantha MinerSmyrna$17K
- Robson SpinolaJesup$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.